Biology Reference
In-Depth Information
Houslay MD, Baillie GS, Maurice DH (2007) cAMP-Specific phosphodiesterase-4 enzymes in the
cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling.
Circ Res 100:950-966
Jimenez JL, Punz´n C, Navarro J, Mu˜oz-Fernandez MA, Fresno M (2001) Phosphodiesterase 4
inhibitors prevent cytokine secretion by Tlymphocytes by inhibiting nuclear factor-kappa
B and nuclear factor of activated T cells activation. J pharmacol Exp Ther 299:753-759
Jin SL, Conti M (2002) Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential
for LPS-activated TNF-alpha responses. Proc Natl Acad Sci USA 99:7628-7633
Jin SL, Richard FJ, Kuo WP, D'Ercole AJ, Conti M (1999) Impaired growth and fertility of cAMP-
specific phosphodiesterase PDE4D-deficient mice. Proc Natl Acad Sci USA 96:11998-12003
Jin SL, Lan L, Zoudilova M, Conti M (2005) Specific role of phosphodiesterase 4B in lipopoly-
saccharide-induced signaling in mouse macrophages. J Immunol 175:1523-1531
Johansson CC, Bryn T, Yndestad A, Eiken HG, Bjerkeli V, Froland SS, Aukrust P, Tasken K
(2004) Cytokine networks are pre-activated in T cells from HIV-infected patients on HAART
and are under the control of cAMP. AIDS 18:171-179
Jordan MS, Singer AL, Koretzky GA (2003) Adaptors as central mediators of signal transduction
in immune cells. Nat Immunol 4:110-116
Kadoshima-Yamaoka K, Murakawa M, Goto M, Tanaka Y, Inoue H, Murafuji H, Hayashi Y,
Nagahira K, Miura K, Nakatsuka T, Chamoto K, Fukuda Y, Nishimura T (2009) Effect of
phosphodiesterase 7 inhibitor ASB16165 on development and function of cytotoxic T lym-
phocyte. Int Immunopharmacol 9:97-102
Kane LP, Weiss A (2003) The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways
downstream of PIP3. Immunol Rev 192:7-20
Kaupp UB, Seifert R (2002) Cyclic nucleotide-gated ion channels. Physiol Rev 82:769-824
Kawabuchi M, Satomi Y, Takao T, Shimonishi Y, Nada S, Nagai K, Tarakhovsky A, Okada M
(2000) Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine
kinases. Nature 404:999-1003
Kawasaki H, Springett GM, Mochizuki N, Toki S, Nakaya M, Matsuda M, Housman DE, Graybiel
AM (1998) A family of cAMP-binding proteins that directly activate Rap1. Science
282:2275-2279
Ke H, Wang H (2007) Crystal structures of phosphodiesterases and implications on substrate
specificity and inhibitor selectivity. Curr Top Med Chem 7:391-403
Kim HH, Tharayil M, Rudd CE (1998) Growth factor receptor-bound protein 2 SH2/SH3 domain
binding to CD28 and its role in co-signaling. J Biol Chem 273:296-301
Kvale D, Ormaasen V, Kran AM, Johansson CC, Aukrust P, Aandahl EM, Froland SS, Tasken K
(2006) Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on
combination antiretroviral treatment. AIDS 20:813-820
Ledbetter JA, Parsons M, Martin PJ, Hansen JA, Rabinovitch PS, June CH (1986)
Antibody binding to CD5 (Tp67) and Tp44 T cell surface molecules: effects on cyclic
nucleotides, cytoplasmic free calcium, and cAMP-mediated suppression. J Immunol 137:
3299-3305
Li L, Yee C, Beavo JA (1999) CD3- and CD28-dependent induction of PDE7 required for T cell
activation. Science 283:848-851
Luan B, Zhao J, Wu H, Duan B, Shu G, Wang X, Li D, Jia W, Kang J, Pei G (2009) Deficiency of a
beta-arrestin-2 signal complex contributes to insulin resistance. Nature 457:1146-1149
Lynch MJ, Baillie GS, Mohamed A, Li X, Maisonneuve C, Klussmann E, van Heeke G,
Houslay MD (2005) RNA silencing identifies PDE4D5 as the functionally relevant cAMP
phosphodiesterase interacting with beta arrestin to control the protein kinase A/AKAP79-
mediated switching of the beta2-adrenergic receptor to activation of ERK in HEK293B2
cells. J Biol Chem 280:33178-33189
Mahic M, Yaqub S, Johansson CC, Tasken K, Aandahl EM (2006) FOXP3
þ
CD4
þ
CD25
þ
adaptive
regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin
E2-dependent mechanism. J Immunol 177:246-254
